Soluble Urokinase‐Type Plasminogen Activator Receptor, Changes of 24‐Hour Blood Pressure, and Progression of Chronic Kidney Disease

BACKGROUND: Soluble urokinase‐type plasminogen activator receptor (suPAR) is associated with cardiovascular risks and poor renal outcomes. However, whether elevated suPAR levels are associated with 24‐hour blood pressure patterns or kidney disease progression in patients with chronic kidney disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Jhee, Jong Hyun, Nam, Bo Young, Lee, Chan Joo, Park, Jung Tak, Han, Seung Hyeok, Kang, Shin‐Wook, Park, Sungha, Yoo, Tae‐Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955457/
https://www.ncbi.nlm.nih.gov/pubmed/33325248
http://dx.doi.org/10.1161/JAHA.120.017225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955457/
https://www.ncbi.nlm.nih.gov/pubmed/33325248
http://dx.doi.org/10.1161/JAHA.120.017225

Ejemplares similares